Novel Gene Therapies for Cystic Fibrosis Continue to Shape Future Global Market
26 Mar 2012
- by Denise Lymperis, Head of Genitourinary and Rare Disorders for GlobalData
Last week in the UK, a groundbreaking gene therapy trial for cystic fibrosis (CF) was announced. This serves as yet another strong indicator that pharmaceutical and biotech companies are increasingly moving into the market with treatments that target the underlying cause of the disease, rather than just the symptoms.
Registering for our Expert Insights is free and only takes a moment.
Following this you'll gain unlimited access to all of the latest, event-driven opinion
put together by our teams of experienced analysts.